HD-OPM Archive
Topics › LDL, ApoB & lipid panel

Louis: forcing LDL-C below 20 in low-risk people is unwise, per Willett on brain bleeds

Louis Nervegna · Mar 30, 2024 · ♥ 9 reactions · 8 comments · original Facebook post
LDL, ApoB & lipid panelHeart attack, stroke & proceduresMyths, misinformation & controversies
AI summary & key facts

Louis criticizes advice for low-risk people to use multiple drugs to push LDL-C below 20, noting major cardiology associations do not recommend it. He quotes Walter Willett saying very low LDL raises hemorrhagic stroke risk, citing Japanese experience and Mendelian randomization of the statin-target gene. The caveat is that high-risk people should push LDL low because heart attack and ischemic stroke risk outweigh this. His rule: LDL target should scale with risk.

Peter Attia’s recommendation that low risk individuals use multiple medications to force their LDL-C less than 20 is irresponsible and dangerous.

There is a good reason that the various cardiology associations around the world, including the American Heart Association, do not recommend that people at low risk for CVD use high doses of drugs to push their LDL cholesterol levels to unnaturally low levels. There are risks involved with doing this. The medications have risks, and there may also be a long term risk from the very low LDL itself.

For example:

Very low LDL cholesterol may increase long term risk for hemorrhagic stroke. That is the opinion of the most famous nutritional epidemiologist in the world, Harvard professor Walter Willett. He explains the possible long term risk of hemorragic stroke from very low LDL in this 5 minute video clip.

Quoting Willett from the video:

“We were meant to have cholesterol and LDL cholesterol. It plays a physiologic role. And driving it down too much does seem… the evidence is quite clear that will increase hemorrhagic stroke risk. This has been studied a lot in Japan, because until fairly recently, hemorrhagic stroke was the #1 cause of death in Japan. A lot of it related to hypertension, but also to very low cholesterol levels. There’s now evidence that statins will do that [increase hemorrhagic stroke risk] if you drive cholesterol down too low, and also Mendelian randomization showing that the genotype that is consistent with the gene that is regulated by statins… that’s also associated with higher hemorrhagic stroke.”

Willett has published over 2000 peer reviewed scientific and medical papers, and was for many years, the second most academically cited author on all of pubmed.

Please note that this does NOT apply to people at higher risk. As Willett explains in the video, the evidence strongly demonstrates that high risk individuals should be pushing their LDL low. For these people, the risk of heart attack and ischemic stroke far outweighs the possible increased risk of hemorrhagic stroke.

Listen to the American Heart Association and the other cardiology associations around the world, and to real experts like Walter Willett. Your LDL target should scale with your level of risk.

#hemorragicstrokeHD #ldlHD #willettHD #harvardHD #peterattiaHD

← newer: Vitamin K2's real value may be improving insulin sensitivityolder: PDE5 inhibitors (Viagra, Cialis) may protect against heart d →